Do analysts recommend RVP or BMRA?

Biomerica has a consensus target price of $9.00, indicating a potential upside of 258.57%. Given Biomerica's stronger consensus rating and higher possible upside, analysts plainly believe Biomerica is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate LUCY or BMRA?

Biomerica has a consensus price target of $9.00, indicating a potential upside of 258.57%. Given Biomerica's higher probable upside, analysts plainly believe Biomerica is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, NXGL or BMRA?

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NexGel $11.42M 0.23 -$3M -$0.71 N/A Biomerica $4.45M 1.74 -$3.78M -$1.27 N/A

Is NXGL or BMRA more profitable?

NexGel has a net margin of -51.26% compared to Biomerica's net margin of -84.79%. Biomerica's return on equity of -97.19% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets NexGel -51.26% -121.18% -41.15% Biomerica -84.79% -97.19% -61.57%

Do analysts recommend BMRA or CUPR?

Biomerica currently has a consensus price target of $9.00, suggesting a potential upside of 258.57%. Given Biomerica's higher possible upside, equities research analysts plainly believe Biomerica is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, BMRA or CUPR?

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biomerica $4.45M 1.74 -$3.78M -$1.27 N/A Cuprina Holdings (Cayman) $40K 41.17 -$3.63M N/A N/A

Do analysts rate LUCYW or BMRA?

Biomerica has a consensus target price of $9.00, suggesting a potential upside of 258.57%. Given Biomerica's stronger consensus rating and higher possible upside, analysts clearly believe Biomerica is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, LUCYW or BMRA?

Innovative Eyewear has higher earnings, but lower revenue than Biomerica. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Innovative Eyewear $3.41M N/A N/A N/A N/A Biomerica $4.45M 1.74 -$3.78M -$1.27 N/A

Biomerica (BMRA) Competitors

$2.51 +0.15 (+6.36%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$2.50 -0.01 (-0.40%)

As of 09/18/2026 07:30 PM Eastern

Compare

BMRA vs. RVP, LUCY, NXGL, CUPR, and LUCYW

Should you buy Biomerica stock or one of its competitors? Biomerica's main competitors and comparable companies include Retractable Technologies (RVP), Innovative Eyewear (LUCY), NexGel (NXGL), Cuprina Holdings (Cayman) (CUPR), and Innovative Eyewear (LUCYW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Biomerica compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

Retractable Technologies has a net margin of -41.11% compared to Biomerica's net margin of -84.79%. Retractable Technologies' return on equity of -17.15% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Biomerica	-84.79%	-97.19%	-61.57%

In the previous week, Retractable Technologies' average media sentiment score of 0.00 equaled Biomerica'saverage media sentiment score.

Company	Overall Sentiment
Retractable Technologies	Neutral
Biomerica	Neutral

Biomerica has lower revenue, but higher earnings than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than Biomerica, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$33.90M	0.64	-$7.01M	-$0.12	N/A
Biomerica	$4.45M	1.74	-$3.78M	-$1.27	N/A

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 22.3% of Biomerica shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Comparatively, 18.0% of Biomerica shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Biomerica has a consensus target price of $9.00, indicating a potential upside of 258.57%. Given Biomerica's stronger consensus rating and higher possible upside, analysts plainly believe Biomerica is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Retractable Technologies has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market. Comparatively, Biomerica has a beta of 0.37, indicating that its stock price is 63% less volatile than the broader market.

Summary

Retractable Technologies beats Biomerica on 8 of the 13 factors compared between the two stocks.

How does Biomerica compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCY) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.

Biomerica has higher revenue and earnings than Innovative Eyewear. Biomerica is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$2.66M	3.07	-$7.59M	-$1.29	N/A
Biomerica	$4.45M	1.74	-$3.78M	-$1.27	N/A

1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 22.3% of Biomerica shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by company insiders. Comparatively, 18.0% of Biomerica shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Innovative Eyewear has a beta of 2.76, meaning that its stock price is 176% more volatile than the broader market. Comparatively, Biomerica has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market.

In the previous week, Innovative Eyewear had 1 more articles in the media than Biomerica. MarketBeat recorded 1 mentions for Innovative Eyewear and 0 mentions for Biomerica. Innovative Eyewear's average media sentiment score of 0.00 equaled Biomerica'saverage media sentiment score.

Company	Overall Sentiment
Innovative Eyewear	Neutral
Biomerica	Neutral

Biomerica has a net margin of -84.79% compared to Innovative Eyewear's net margin of -225.26%. Innovative Eyewear's return on equity of -88.90% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	-225.26%	-88.90%	-80.34%
Biomerica	-84.79%	-97.19%	-61.57%

Biomerica has a consensus price target of $9.00, indicating a potential upside of 258.57%. Given Biomerica's higher probable upside, analysts plainly believe Biomerica is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Biomerica beats Innovative Eyewear on 8 of the 14 factors compared between the two stocks.

How does Biomerica compare to NexGel?

NexGel (NASDAQ:NXGL) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

NexGel presently has a consensus target price of $2.00, indicating a potential upside of 652.45%. Biomerica has a consensus target price of $9.00, indicating a potential upside of 258.57%. Given NexGel's stronger consensus rating and higher probable upside, equities analysts clearly believe NexGel is more favorable than Biomerica.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

2.2% of NexGel shares are owned by institutional investors. Comparatively, 22.3% of Biomerica shares are owned by institutional investors. 19.8% of NexGel shares are owned by insiders. Comparatively, 18.0% of Biomerica shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, NexGel had 2 more articles in the media than Biomerica. MarketBeat recorded 2 mentions for NexGel and 0 mentions for Biomerica. NexGel's average media sentiment score of 0.46 beat Biomerica's score of 0.00 indicating that NexGel is being referred to more favorably in the media.

Company	Overall Sentiment
NexGel	Neutral
Biomerica	Neutral

NexGel has a net margin of -51.26% compared to Biomerica's net margin of -84.79%. Biomerica's return on equity of -97.19% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-51.26%	-121.18%	-41.15%
Biomerica	-84.79%	-97.19%	-61.57%

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$11.42M	0.23	-$3M	-$0.71	N/A
Biomerica	$4.45M	1.74	-$3.78M	-$1.27	N/A

NexGel has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Biomerica has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market.

Summary

NexGel beats Biomerica on 12 of the 15 factors compared between the two stocks.

How does Biomerica compare to Cuprina Holdings (Cayman)?

Biomerica (NASDAQ:BMRA) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Biomerica has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of -0.37, meaning that its stock price is 137% less volatile than the broader market.

22.3% of Biomerica shares are held by institutional investors. 18.0% of Biomerica shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Cuprina Holdings (Cayman) had 5 more articles in the media than Biomerica. MarketBeat recorded 5 mentions for Cuprina Holdings (Cayman) and 0 mentions for Biomerica. Cuprina Holdings (Cayman)'s average media sentiment score of 0.22 beat Biomerica's score of 0.00 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media.

Company	Overall Sentiment
Biomerica	Neutral
Cuprina Holdings (Cayman)	Neutral

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Biomerica's net margin of -84.79%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biomerica	-84.79%	-97.19%	-61.57%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

Biomerica currently has a consensus price target of $9.00, suggesting a potential upside of 258.57%. Given Biomerica's higher possible upside, equities research analysts plainly believe Biomerica is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biomerica	$4.45M	1.74	-$3.78M	-$1.27	N/A
Cuprina Holdings (Cayman)	$40K	41.17	-$3.63M	N/A	N/A

Summary

Cuprina Holdings (Cayman) beats Biomerica on 7 of the 12 factors compared between the two stocks.

How does Biomerica compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCYW) and Biomerica (NASDAQ:BMRA) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

22.3% of Biomerica shares are owned by institutional investors. 18.0% of Biomerica shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Innovative Eyewear has higher earnings, but lower revenue than Biomerica.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$3.41M	N/A	N/A	N/A	N/A
Biomerica	$4.45M	1.74	-$3.78M	-$1.27	N/A

Biomerica has a consensus target price of $9.00, suggesting a potential upside of 258.57%. Given Biomerica's stronger consensus rating and higher possible upside, analysts clearly believe Biomerica is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Innovative Eyewear's average media sentiment score of 0.00 equaled Biomerica'saverage media sentiment score.

Company	Overall Sentiment
Innovative Eyewear	Neutral
Biomerica	Neutral

Innovative Eyewear has a net margin of 0.00% compared to Biomerica's net margin of -84.79%. Innovative Eyewear's return on equity of 0.00% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	N/A	N/A	N/A
Biomerica	-84.79%	-97.19%	-61.57%

Summary

Biomerica beats Innovative Eyewear on 5 of the 8 factors compared between the two stocks.

Get Biomerica News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BMRA vs. The Competition

Export

Metric	Biomerica	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$7.76M	$5.55B	$7.24B	$13.19B
Dividend Yield	N/A	1.80%	2.57%	12.81%
P/E Ratio	-1.98	25.34	275.49	25.40
Price / Sales	1.74	72.49	646.01	89.45
Price / Cash	N/A	32.64	76.25	51.42
Price / Book	2.95	5.69	10.46	6.33
Net Income	-$3.78M	$151.55M	$3.49B	$358.33M
7 Day Performance	12.05%	0.66%	0.59%	1.12%
1 Month Performance	58.36%	-3.33%	-1.74%	-2.39%
1 Year Performance	-12.85%	6.79%	18.13%	5.35%

Biomerica Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BMRA Biomerica	2.0644 of 5 stars	$2.51 +6.4%	$9.00 +258.6%	-12.8%	$7.76M	$4.45M	N/A	50
RVP Retractable Technologies	N/A	$0.71 +2.0%	N/A	-14.5%	$21.38M	$33.90M	N/A	240	Gap Up
LUCY Innovative Eyewear	0.3514 of 5 stars	$0.85 -2.1%	N/A	-51.0%	$7.31M	$3.41M	N/A	9
NXGL NexGel	1.9188 of 5 stars	$0.30 -0.8%	$2.00 +578.0%	-89.8%	$2.89M	$12.07M	N/A	10
CUPR Cuprina Holdings (Cayman)	0.9404 of 5 stars	$3.06 -2.1%	N/A	N/A	$2.81M	$40K	N/A	14	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BMRA) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biomerica (BMRA) Competitors

BMRA vs. RVP, LUCY, NXGL, CUPR, and LUCYW

How does Biomerica compare to Retractable Technologies?

Summary

How does Biomerica compare to Innovative Eyewear?

Summary

How does Biomerica compare to NexGel?

Summary

How does Biomerica compare to Cuprina Holdings (Cayman)?

Summary

How does Biomerica compare to Innovative Eyewear?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMRA vs. The Competition

Biomerica Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biomerica (BMRA) Competitors

BMRA vs. RVP, LUCY, NXGL, CUPR, and LUCYW

How does Biomerica compare to Retractable Technologies?

Is RVP or BMRA more profitable?

Does the media prefer RVP or BMRA?

Which has preferable valuation and earnings, RVP or BMRA?

Do institutionals and insiders have more ownership in RVP or BMRA?

Do analysts recommend RVP or BMRA?

Which has more volatility and risk, RVP or BMRA?

Summary

How does Biomerica compare to Innovative Eyewear?

Which has better earnings and valuation, LUCY or BMRA?

Do institutionals & insiders have more ownership in LUCY or BMRA?

Which has more risk and volatility, LUCY or BMRA?

Does the media favor LUCY or BMRA?

Is LUCY or BMRA more profitable?

Do analysts rate LUCY or BMRA?

Summary

How does Biomerica compare to NexGel?

Do analysts rate NXGL or BMRA?

Do insiders & institutionals have more ownership in NXGL or BMRA?

Does the media favor NXGL or BMRA?

Is NXGL or BMRA more profitable?

Which has higher valuation and earnings, NXGL or BMRA?

Which has more risk & volatility, NXGL or BMRA?

Summary

How does Biomerica compare to Cuprina Holdings (Cayman)?

Which has more volatility and risk, BMRA or CUPR?

Do institutionals and insiders hold more shares of BMRA or CUPR?

Does the media refer more to BMRA or CUPR?

Is BMRA or CUPR more profitable?

Do analysts recommend BMRA or CUPR?

Which has stronger valuation and earnings, BMRA or CUPR?

Summary

How does Biomerica compare to Innovative Eyewear?

Do insiders and institutionals hold more shares of LUCYW or BMRA?

Which has stronger valuation & earnings, LUCYW or BMRA?

Do analysts rate LUCYW or BMRA?

Does the media prefer LUCYW or BMRA?

Is LUCYW or BMRA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BMRA vs. The Competition

Biomerica Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools